LifeMD, Inc. Class Action Lawsuit: Key Updates for Investors

Author: Evelyn Baker Updated: 09-19-2025 09:00 AM

LifeMD, Inc. Faces Class Action Lawsuit - What Investors Need to Know

Levi & Korsinsky, LLP is reaching out to investors regarding an important class action lawsuit involving LifeMD, Inc. (NASDAQ: LFMD). This is crucial for shareholders who may have suffered losses during the specific time frame outlined in the lawsuit.

Understanding the Class Action Lawsuit

The lawsuit aims to address grievances faced by investors adversely impacted by alleged securities fraud. It specifically covers a period of time where key concerns were raised about the accuracy of LifeMD's financial disclosures. The allegations include significant misstatements regarding the company's competitive position and the inflation of its revenue forecasts.

Key Allegations Against LifeMD

According to the lawsuit, the defendants, including executives at LifeMD, made false claims that misled investors about the company's business operations. It was stated that LifeMD's guidance for 2025 did not accurately reflect the growing customer acquisition costs associated with critical segments of its business, particularly in the sale of obesity treatment drugs. These statements were deemed materially misleading, affecting investor decisions.

Important Deadlines for Investors

Investors in LifeMD, Inc. have until October 25, 2025, to act regarding this lawsuit. Those who have incurred losses during the specified period should consider seeking the appointment as lead plaintiff in the case. However, it’s noteworthy that participation in any potential recovery does not require being a lead plaintiff.

No Financial Risk to Class Members

Individuals who qualify as class members in this lawsuit have the opportunity to seek compensation without any upfront costs or fees. This means that participation comes with no financial obligation, which can greatly benefit those who were misled.

Why Choose Levi & Korsinsky?

Levi & Korsinsky has earned a distinguished reputation over the past two decades, securing substantial settlements for investors embroiled in complex securities disputes. Their expertise in this field, along with a dedicated team of over 70 professionals, showcases their commitment to representing investor interests effectively. The firm has been recognized consistently, including a notable placement in the ISS Securities Class Action Services' Top 50 Report.

Contact Information for Assistance

For investors who wish to reach out for more details or assistance concerning this lawsuit, please contact:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
Tel: (212) 363-7500
Fax: (212) 363-7171

Frequently Asked Questions

What is the class action lawsuit against LifeMD about?

The lawsuit addresses allegations of securities fraud that negatively impacted LifeMD investors, specifically false statements and misleading guidance.

What is the deadline for investors?

Investors have until October 25, 2025, to request to be appointed as lead plaintiff in the lawsuit.

How can investors participate in the lawsuit?

Investors can join the lawsuit without needing to be the lead plaintiff, and they may be eligible for compensation without facing any costs.

Why should investors trust Levi & Korsinsky?

Levi & Korsinsky has a strong track record of securing favorable outcomes for shareholders and is recognized as a leading firm in securities litigation.

Who can I contact for more information?

Interested investors can contact Levi & Korsinsky at their New York office or by calling (212) 363-7500 for further assistance regarding the lawsuit.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.